| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Editing | 16 | 2025 | 212 | 3.430 |
Why?
|
| Dependovirus | 16 | 2025 | 154 | 2.920 |
Why?
|
| CRISPR-Cas Systems | 12 | 2022 | 293 | 2.740 |
Why?
|
| Genetic Vectors | 13 | 2025 | 927 | 2.320 |
Why?
|
| Liver | 19 | 2025 | 1815 | 2.000 |
Why?
|
| Genetic Therapy | 12 | 2025 | 720 | 1.870 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 4 | 2020 | 73 | 1.770 |
Why?
|
| Receptors, LDL | 6 | 2018 | 104 | 1.330 |
Why?
|
| Lipid Metabolism | 5 | 2019 | 389 | 1.260 |
Why?
|
| Atherosclerosis | 7 | 2023 | 1000 | 1.260 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 4 | 2020 | 33 | 1.240 |
Why?
|
| Hepatocytes | 6 | 2025 | 241 | 1.200 |
Why?
|
| Apolipoproteins | 5 | 2014 | 72 | 1.190 |
Why?
|
| Metabolic Diseases | 2 | 2023 | 139 | 1.190 |
Why?
|
| Gene Targeting | 3 | 2025 | 174 | 0.990 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 2062 | 0.960 |
Why?
|
| Animals | 53 | 2025 | 34989 | 0.910 |
Why?
|
| Genes, Essential | 1 | 2025 | 43 | 0.900 |
Why?
|
| Viral Tropism | 1 | 2025 | 53 | 0.880 |
Why?
|
| Mice | 37 | 2025 | 18571 | 0.850 |
Why?
|
| Transgenes | 5 | 2025 | 336 | 0.840 |
Why?
|
| Cholesterol, HDL | 6 | 2017 | 395 | 0.820 |
Why?
|
| Hypercholesterolemia | 3 | 2022 | 232 | 0.750 |
Why?
|
| Terpenes | 1 | 2020 | 30 | 0.680 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2020 | 126 | 0.670 |
Why?
|
| Cholesterol | 9 | 2023 | 559 | 0.670 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 188 | 0.650 |
Why?
|
| Lipids | 4 | 2019 | 562 | 0.650 |
Why?
|
| Mice, Knockout | 14 | 2023 | 3873 | 0.560 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 228 | 0.550 |
Why?
|
| Intestines | 1 | 2022 | 611 | 0.550 |
Why?
|
| Lipoproteins, HDL | 4 | 2017 | 117 | 0.550 |
Why?
|
| Stem Cells | 2 | 2022 | 732 | 0.550 |
Why?
|
| Gene Transfer Techniques | 4 | 2019 | 350 | 0.530 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 1294 | 0.490 |
Why?
|
| Carrier Proteins | 3 | 2021 | 1049 | 0.490 |
Why?
|
| Dyslipidemias | 1 | 2019 | 242 | 0.480 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 4695 | 0.480 |
Why?
|
| Phospholipid Transfer Proteins | 2 | 2017 | 17 | 0.480 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 4767 | 0.460 |
Why?
|
| Spasms, Infantile | 1 | 2016 | 175 | 0.430 |
Why?
|
| STAT2 Transcription Factor | 1 | 2014 | 3 | 0.430 |
Why?
|
| Genome | 1 | 2017 | 502 | 0.430 |
Why?
|
| Interferon Type I | 1 | 2014 | 114 | 0.410 |
Why?
|
| Capsid | 2 | 2023 | 147 | 0.390 |
Why?
|
| Lipoproteins | 2 | 2015 | 188 | 0.390 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1598 | 0.310 |
Why?
|
| Electroporation | 1 | 2007 | 34 | 0.270 |
Why?
|
| Apolipoproteins B | 3 | 2023 | 146 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 3358 | 0.250 |
Why?
|
| Gene Expression | 4 | 2020 | 1564 | 0.250 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2018 | 246 | 0.240 |
Why?
|
| Male | 21 | 2025 | 65052 | 0.240 |
Why?
|
| Humans | 26 | 2025 | 132334 | 0.230 |
Why?
|
| Fatty Acids | 2 | 2019 | 365 | 0.230 |
Why?
|
| Hydrolases | 1 | 2025 | 61 | 0.230 |
Why?
|
| Serogroup | 1 | 2025 | 63 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 246 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 145 | 0.220 |
Why?
|
| Tissue Distribution | 1 | 2025 | 383 | 0.220 |
Why?
|
| Plasmids | 4 | 2018 | 459 | 0.220 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 294 | 0.210 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 652 | 0.210 |
Why?
|
| Signal Transduction | 3 | 2021 | 4725 | 0.210 |
Why?
|
| Mice, Transgenic | 8 | 2025 | 2453 | 0.210 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2023 | 4 | 0.200 |
Why?
|
| Myotonic Dystrophy | 1 | 2025 | 150 | 0.200 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2015 | 111 | 0.200 |
Why?
|
| Phospholipids | 3 | 2014 | 105 | 0.190 |
Why?
|
| Mutation | 6 | 2018 | 6248 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 157 | 0.190 |
Why?
|
| Lysine | 1 | 2023 | 201 | 0.190 |
Why?
|
| Sterols | 1 | 2022 | 16 | 0.190 |
Why?
|
| Gene Deletion | 2 | 2020 | 795 | 0.190 |
Why?
|
| Acyl Coenzyme A | 1 | 2022 | 24 | 0.190 |
Why?
|
| Lipase | 2 | 2014 | 98 | 0.180 |
Why?
|
| Lipoprotein(a) | 1 | 2023 | 138 | 0.180 |
Why?
|
| Chondrogenesis | 1 | 2021 | 28 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 215 | 0.180 |
Why?
|
| DNA Repair | 1 | 2025 | 567 | 0.180 |
Why?
|
| Adenoviridae | 3 | 2022 | 596 | 0.180 |
Why?
|
| Muscles | 1 | 2021 | 251 | 0.180 |
Why?
|
| Cells | 1 | 2021 | 24 | 0.180 |
Why?
|
| Cilia | 1 | 2021 | 79 | 0.170 |
Why?
|
| Limb Deformities, Congenital | 1 | 2021 | 112 | 0.170 |
Why?
|
| Mevalonic Acid | 1 | 2020 | 21 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 135 | 0.170 |
Why?
|
| Osteogenesis | 1 | 2021 | 163 | 0.170 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 273 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2018 | 714 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 605 | 0.170 |
Why?
|
| Phenotype | 6 | 2025 | 4545 | 0.160 |
Why?
|
| Gene Order | 1 | 2020 | 82 | 0.160 |
Why?
|
| Diet, Western | 1 | 2019 | 18 | 0.160 |
Why?
|
| Biological Transport | 4 | 2017 | 358 | 0.160 |
Why?
|
| Myocardium | 1 | 2025 | 908 | 0.160 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2019 | 32 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 1042 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 21 | 0.160 |
Why?
|
| Luciferases | 4 | 2009 | 129 | 0.160 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2019 | 35 | 0.160 |
Why?
|
| Female | 12 | 2025 | 70786 | 0.160 |
Why?
|
| Immunophenotyping | 1 | 2020 | 344 | 0.150 |
Why?
|
| Heat-Shock Proteins | 1 | 2020 | 183 | 0.150 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 16 | 0.150 |
Why?
|
| RNAi Therapeutics | 1 | 2019 | 17 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 210 | 0.150 |
Why?
|
| Immunization | 1 | 2020 | 312 | 0.150 |
Why?
|
| Immunologic Memory | 1 | 2020 | 199 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 124 | 0.140 |
Why?
|
| Exons | 2 | 2023 | 803 | 0.140 |
Why?
|
| Cell Lineage | 1 | 2020 | 359 | 0.140 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 79 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 194 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2019 | 156 | 0.140 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 65 | 0.140 |
Why?
|
| Proprotein Convertase 9 | 1 | 2018 | 82 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2019 | 1061 | 0.140 |
Why?
|
| Regeneration | 1 | 2020 | 226 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 399 | 0.140 |
Why?
|
| Monocytes | 1 | 2019 | 345 | 0.140 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2018 | 76 | 0.130 |
Why?
|
| Rats | 5 | 2023 | 3619 | 0.130 |
Why?
|
| Genes, Reporter | 3 | 2019 | 365 | 0.130 |
Why?
|
| Genome, Human | 2 | 2021 | 1332 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 58 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 691 | 0.130 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 156 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2018 | 206 | 0.120 |
Why?
|
| Apoptosis | 2 | 2020 | 1903 | 0.120 |
Why?
|
| Heart Atria | 1 | 2019 | 333 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2018 | 330 | 0.120 |
Why?
|
| Cholesterol Esters | 1 | 2015 | 16 | 0.120 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 99 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2018 | 443 | 0.120 |
Why?
|
| CD36 Antigens | 1 | 2015 | 42 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 39 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 52 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2512 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 368 | 0.120 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 143 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 578 | 0.110 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 2446 | 0.110 |
Why?
|
| Macrophages | 4 | 2017 | 693 | 0.110 |
Why?
|
| Apolipoprotein A-I | 2 | 2011 | 89 | 0.110 |
Why?
|
| Calcium | 2 | 2017 | 1083 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2015 | 256 | 0.100 |
Why?
|
| Anticholesteremic Agents | 1 | 2015 | 239 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 1227 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2014 | 796 | 0.100 |
Why?
|
| Muscle Proteins | 3 | 2023 | 411 | 0.100 |
Why?
|
| Aorta | 2 | 2014 | 554 | 0.100 |
Why?
|
| Base Sequence | 1 | 2017 | 2904 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1831 | 0.100 |
Why?
|
| Pedigree | 1 | 2016 | 1725 | 0.100 |
Why?
|
| Capsid Proteins | 2 | 2023 | 195 | 0.090 |
Why?
|
| Calcium Signaling | 3 | 2019 | 254 | 0.090 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 139 | 0.090 |
Why?
|
| Glycosylation | 1 | 2012 | 126 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2012 | 310 | 0.090 |
Why?
|
| Cholesterol, LDL | 2 | 2015 | 602 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 947 | 0.090 |
Why?
|
| Protein Binding | 3 | 2020 | 1733 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2012 | 182 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2014 | 513 | 0.090 |
Why?
|
| Thyroid Hormones | 1 | 2011 | 56 | 0.090 |
Why?
|
| Transfection | 3 | 2009 | 999 | 0.090 |
Why?
|
| Biomarkers | 1 | 2020 | 3389 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 2 | 2021 | 86 | 0.080 |
Why?
|
| Triglycerides | 2 | 2014 | 615 | 0.080 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 255 | 0.080 |
Why?
|
| Vasodilation | 1 | 2011 | 180 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 196 | 0.080 |
Why?
|
| Genotype | 1 | 2016 | 2706 | 0.080 |
Why?
|
| Insulin | 2 | 2005 | 1210 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 365 | 0.080 |
Why?
|
| Lipoproteins, HDL2 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Lipoproteins, HDL3 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 138 | 0.080 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2009 | 3 | 0.080 |
Why?
|
| Heart Failure | 2 | 2019 | 2386 | 0.080 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 83 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2025 | 1997 | 0.070 |
Why?
|
| Response Elements | 2 | 2005 | 98 | 0.070 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 160 | 0.070 |
Why?
|
| Neurons | 1 | 2018 | 2016 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 813 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2020 | 679 | 0.070 |
Why?
|
| Lovastatin | 1 | 2007 | 23 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2008 | 332 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 879 | 0.060 |
Why?
|
| Microsomes, Liver | 1 | 2007 | 100 | 0.060 |
Why?
|
| Antioxidants | 1 | 2009 | 335 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2012 | 728 | 0.060 |
Why?
|
| DNA Footprinting | 1 | 2005 | 15 | 0.060 |
Why?
|
| CCAAT-Binding Factor | 1 | 2005 | 6 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 54 | 0.060 |
Why?
|
| Cholesterol, Dietary | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 98 | 0.060 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2025 | 45 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 236 | 0.060 |
Why?
|
| Proteomics | 1 | 2009 | 594 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2010 | 1583 | 0.050 |
Why?
|
| Apoprotein(a) | 1 | 2023 | 6 | 0.050 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2023 | 67 | 0.050 |
Why?
|
| Apolipoprotein B-100 | 1 | 2023 | 39 | 0.050 |
Why?
|
| Cell Line | 1 | 2008 | 2730 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1975 | 0.050 |
Why?
|
| Apolipoproteins A | 1 | 2023 | 54 | 0.050 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2023 | 14 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2023 | 197 | 0.050 |
Why?
|
| Obesity | 3 | 2023 | 2406 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 3697 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2023 | 93 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 490 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13016 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 67 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2025 | 364 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 1285 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 459 | 0.050 |
Why?
|
| APOBEC-1 Deaminase | 2 | 2012 | 12 | 0.050 |
Why?
|
| Cytidine Deaminase | 2 | 2012 | 32 | 0.050 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2023 | 112 | 0.050 |
Why?
|
| Kidney | 1 | 2008 | 1331 | 0.050 |
Why?
|
| Cartilage | 1 | 2021 | 51 | 0.050 |
Why?
|
| Chondrocytes | 1 | 2021 | 51 | 0.050 |
Why?
|
| Energy Metabolism | 2 | 2018 | 804 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 284 | 0.040 |
Why?
|
| Kinetics | 2 | 2015 | 1178 | 0.040 |
Why?
|
| Models, Biological | 2 | 2020 | 1458 | 0.040 |
Why?
|
| Infant | 1 | 2016 | 13192 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 164 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 1426 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 201 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 134 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 63 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2020 | 54 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 301 | 0.040 |
Why?
|
| Peptides | 1 | 2023 | 847 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 137 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2009 | 2494 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 49 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 699 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2020 | 121 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 121 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2012 | 304 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 165 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 42 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2018 | 101 | 0.040 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2018 | 35 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 500 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Recombinational DNA Repair | 1 | 2017 | 19 | 0.030 |
Why?
|
| High-Density Lipoproteins, Pre-beta | 1 | 2017 | 1 | 0.030 |
Why?
|
| Public Opinion | 1 | 2017 | 62 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2018 | 210 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 378 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2017 | 142 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 374 | 0.030 |
Why?
|
| Risk Factors | 1 | 2010 | 10910 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2017 | 347 | 0.030 |
Why?
|
| Estrogens | 1 | 2018 | 435 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 161 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 489 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 573 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2015 | 173 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 201 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 527 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 199 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 3022 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 144 | 0.030 |
Why?
|
| Plasmalogens | 1 | 2014 | 4 | 0.030 |
Why?
|
| Diglycerides | 1 | 2014 | 17 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 2014 | 36 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1353 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 514 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2014 | 138 | 0.030 |
Why?
|
| Body Weight | 1 | 2018 | 1005 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 730 | 0.030 |
Why?
|
| United States | 2 | 2021 | 11627 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1555 | 0.030 |
Why?
|
| Adiponectin | 1 | 2014 | 128 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 160 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 412 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 778 | 0.020 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2012 | 11 | 0.020 |
Why?
|
| Leptin | 1 | 2014 | 219 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2017 | 800 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 751 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2011 | 22 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2011 | 70 | 0.020 |
Why?
|
| Particle Size | 1 | 2011 | 149 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 381 | 0.020 |
Why?
|
| Lipoproteins, VLDL | 1 | 2010 | 57 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2010 | 60 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 162 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 539 | 0.020 |
Why?
|
| Centrifugation, Isopycnic | 1 | 2009 | 1 | 0.020 |
Why?
|
| Esterases | 1 | 2009 | 12 | 0.020 |
Why?
|
| Aryldialkylphosphatase | 1 | 2009 | 9 | 0.020 |
Why?
|
| Apolipoprotein L1 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2009 | 10 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2009 | 60 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 544 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 717 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 243 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1046 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 3980 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2014 | 917 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 480 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1253 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 3062 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 7567 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2687 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8566 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2004 | 234 | 0.010 |
Why?
|
| Child | 1 | 2015 | 25823 | 0.010 |
Why?
|